Elizabeth A Juma

Summary

Affiliation: Kenya Medical Research Institute
Country: Kenya

Publications

  1. pmc A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
    Elizabeth A Juma
    Kenya Medical Research Institute, Centre for Global Health Research, PO Box 1578, 40100 Kisumu, Kenya
    Malar J 7:262. 2008
  2. ncbi Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis
    Charles O Obonyo
    Centre for Vector Biology and Control Research, Kenya Medical Research Institute, PO Box 1578 40100, Kisumu, Kenya
    Trans R Soc Trop Med Hyg 101:117-26. 2007
  3. pmc Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis
    Charles O Obonyo
    Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
    Malar J 11:2. 2012

Detail Information

Publications3

  1. pmc A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
    Elizabeth A Juma
    Kenya Medical Research Institute, Centre for Global Health Research, PO Box 1578, 40100 Kisumu, Kenya
    Malar J 7:262. 2008
    ..However, oral paediatric formulations are urgently needed, as the tablets are difficult to administer to young children, who cannot swallow whole tablets or tolerate the bitter taste of the crushed tablets...
  2. ncbi Amodiaquine combined with sulfadoxine/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis
    Charles O Obonyo
    Centre for Vector Biology and Control Research, Kenya Medical Research Institute, PO Box 1578 40100, Kisumu, Kenya
    Trans R Soc Trop Med Hyg 101:117-26. 2007
    ..12, 95% CI 0.81-1.54), but there was significant heterogeneity of results across the studies. All the treatment regimens were safe and well tolerated. AQ+SP should be considered in some settings before the full implementation of an ACT...
  3. pmc Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis
    Charles O Obonyo
    Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
    Malar J 11:2. 2012
    ..The efficacy and safety of clindamycin plus quinine is not known. This systematic review aims to assess the efficacy of clindamycin plus quinine versus other anti-malarial drugs in the treatment of uncomplicated falciparum malaria...